AI Summary
PFE (PFE) is currently trading at $27.23, up 2.12% in the last 24 hours. We maintain a HOLD rating pending clearer directional signals.
Price
Volume
P/E Ratio
Insider
Price Chart
Price Data
Fundamentals
Technical Analysis Summary
27 indicators analyzed
Technical signals are mixed with 14 bullish and 7 bearish indicators. Wait for clearer direction before taking new positions.
Technical Indicators
Momentum & trend signals
💡 Technical indicators are tools, not guarantees. Always combine with fundamental analysis.
MACD
(12, 26, 9)Bollinger Bands
Volatility & breakout detection
Stochastic Oscillator
Momentum indicator (14,3,3)
📊 Neutral: PFE stochastic is in the middle range (93.8). Wait for %K to enter overbought (80+) or oversold (20-) zones for clearer signals.
Average True Range (ATR)
📊 Volatility increasing - consider wider stops to avoid getting stopped out.
On-Balance Volume (OBV)
Volume-based momentum indicator
📈 Volume confirms uptrend: OBV rising above its average suggests institutional accumulation. Bullish signal for trend continuation.
Pivot Points
Key Support & Resistance Levels
All Pivot Levels
Price is trading above the pivot point at $26.71, indicating bullish bias. Watch R1 ($26.97) as the next target.
Fibonacci Retracement
| Level | Price | Type | Distance |
|---|---|---|---|
| 0% | $27.69 | Resistance | -1.7% |
| 23.6% | $26.09 | Support | +4.2% |
| 38.2% | $25.10 | Support | +7.8% |
| 50%✦ | $24.31 | Support | +10.7% |
| 61.8%✦ | $23.51 | Support | +13.7% |
| 78.6% | $22.37 | Support | +17.8% |
| 100% | $20.92 | Support | +23.2% |
VWAP (Volume Weighted Avg Price)
Parabolic SAR
Stop and Reverse Indicator
🔄 TREND REVERSAL: SAR just flipped bullish! New uptrend starting. Consider long positions with SAR as trailing stop.
Williams %R
📈 OVERBOUGHT: Williams %R at -6.2 indicates the stock is trading near its 14-day high. Strong momentum continues - may stay overbought in uptrends.
📊 CCI (Commodity Channel Index)
Momentum oscillator measuring price deviation
Strength: 50%
Previous CCI
+150.9
Typical Price
$27.06
SMA (20)
$25.94
Mean Deviation
$0.42
📈 OVERBOUGHT: CCI at 176.7 (above +100) indicates strong bullish momentum. Uptrend intact - ride the trend but watch for reversal signs.
20-Day CCI History
🎯Aroon Indicator(25-period)
📈 STRONG UPTREND: Aroon Up at 100 (above 70) with Aroon Down at 4 (below 30). Price made its 25-day high 0 day(s) ago. Trend is healthy - stay long and trail stops. Oscillator at 96.0 shows bullish bias.
📊 Rate of Change (ROC)Buy
BullishUltimate Oscillator
Multi-timeframe momentum (7, 14, 28)
Keltner Channels
ATR-based volatility bands
↗️ NEAR UPPER BAND: Price 27.23 approaching resistance at 27.50. Uptrend may push through - watch for breakout.
TTM Squeeze
John Carter's Volatility Breakout
📈 NO SQUEEZE - BULLISH MOMENTUM: No squeeze currently (bands expanded). Momentum is positive and rising (0.55) - bullish continuation likely. Watch for momentum to strengthen for confirmation.
Elder Ray (Bull/Bear Power)
Dr. Alexander Elder's Power Index
🚀 Strong bullish pressure - both bulls and bears above their normal ranges, bulls in control.
Force Index
Dr. Alexander Elder's Volume-Price Momentum
🐂 Bulls in control! Both short-term (20.74M) and medium-term (6.98M) force positive and rising. Volume confirms normal participation.
Williams Alligator
Trend Direction & Strength
😋 Alligator is SATED - trend is losing momentum. Lines are converging. Previous bullish trend may be ending. Consider taking profits and wait for the next opportunity.
Donchian Channels
Richard Donchian's Breakout System (20-period)
Price broke above the 20-day high of $27.36
🚀 BULLISH BREAKOUT! Price $27.23 broke above the 20-day high of $27.19. Weak breakout strength. Donchian breakouts often signal the start of new trends - consider long entries with stops below the middle band ($26.17).
Supertrend
ATR-Based Trend Following
📉 DOWNTREND active for 53 days. Price $27.24 is 3.2% below Supertrend $26.38. Moderate trend strength. The Supertrend line acts as resistance - avoid longs until bullish crossover.
Choppiness Index
Trend vs Range Detection (14-period)
⏳ TRANSITIONAL MARKET (CHOP: 55.2). The market is between trending and ranging. Choppiness is stable. Trading advice: WAIT for clearer signals or use smaller position sizes.
Valuation Metrics
Relative value indicators
💡 PEG < 1 suggests undervalued relative to growth • EV/EBITDA accounts for debt
Historical Returns
Price performance across timeframes
📈 Insight: Strong recent momentum with positive year-to-date performance. Consider trailing stop to protect gains.
Seasonality Analysis
Market Comparison
Performance vs S&P 500
Dividend History
Past payments & growth
| Ex-Date | Amount |
|---|---|
| Jan 23, 2026Latest | $0.4300 |
| Nov 7, 2025 | $0.4300 |
| Jul 25, 2025 | $0.4300 |
| May 9, 2025 | $0.4300 |
| Jan 24, 2025 | $0.4300 |
| Nov 8, 2024 | $0.4200 |
| Jul 26, 2024 | $0.4200 |
| May 9, 2024 | $0.4200 |
Growth Metrics
Year-over-year performance
Growth rates calculated from trailing twelve months vs prior period
Analyst EPS Estimates
Consensus earnings projections
| Fiscal Year | Est. EPS | YoY Growth |
|---|---|---|
| FY26 | $2.96 | +71.2% |
| FY27 | $2.82 | -4.7% |
| FY28 | $2.11 | -25.2% |
Based on analyst consensus estimates. Actual results may vary.
Insider Activity
| Date | Insider | Type | Shares | Value |
|---|---|---|---|---|
| Invalid Date | Unknown | SELL | 0 | $0K |
| Invalid Date | Unknown | SELL | 0 | $0K |
| Invalid Date | Unknown | SELL | 0 | $0K |
| Invalid Date | Unknown | SELL | 0 | $0K |
| Invalid Date | Unknown | SELL | 0 | $0K |
Recent News
Anti-Obesity Drugs Market to Reach US$195.99 Billion by 2036 as GLP-1 Therapies Drive a Structural Shift in Weight Management
Obesity Treatment Market Size to Reach USD 75.69 Billion by 2033 as the Treatment Offers a Comprehensive Evaluation of Therapeutic Developments Globally
Human Vaccines Market Size to Reach USD 62.45 Billion by 2033, Driven by Expanding Immunization Programs – SNS Insider

Will the Market Crash in 2026? Here's What History Says and What to Do About It

Why 2026 Could Be the Year Pfizer's Stock Finally Takes Off

Why Pfizer Stock Dropped Today

Pfizer's Newly Acquired Drug Shows Weight Loss Of Just Around 13%, Stock Drops
OTC/DTC Infectious Disease Diagnostics Research Report 2026: Market Strategies, Trends, and Forecasts 2025-2029 - Privacy, Digital Access, and Rapid Results Accelerate Adoption
Targeted Cancer Therapy Market to Reach US$ 175.48 Billion by 2035 Driven by Precision Oncology Adoption, ADC Innovation, and Regulatory Productivity Says Astute Analytica

3 Headwinds Facing Pfizer in 2026
💪 Strengths
- ✓Limited positive signals in current data
🚀 Opportunities
- →Market conditions could present buying opportunities
⚠️ Weaknesses
- !No significant weaknesses identified
🛑 Threats
- ✕Broader market volatility remains a risk
⚡ Catalysts
- ★Earnings releases and guidance updates
⚠️ Key Risks
- !Standard market and sector risks apply
Are you an AI agent?
Help improve this research! Submit corrections, updates, or suggestions via Moltbook.
AI Agent Feedback
Are you an AI agent? Help improve this analysis!